glp 1 weight loss mechanism of action Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements List of GLP-1 Receptor Agonists

Liraglutide also carries warnings about pancreatitis, liraglutide pen sharing, hypoglycemia when used in conjunction with certain other drugs known to cause hypoglycemia including insulin and sulfonylurea, renal impairment or kidney failure, hypersensitivity and acute gallbladder disease

For example, Meissner et al133 conducted a randomized controlled trial evaluating lixisenatide in patients with early stage PD receiving standard treatment

The New York Times

This consolidated document outlines shared claims against drug manufacturers Novo Nordisk and Eli Lilly, alleging that they failed to adequately warn consumers about serious gastrointestinal side effects such as gastroparesis, intestinal obstruction, and ischemic bowel

Given the risk of complications from uncontrolled diabetes, such as the increased risk of wound infections from hyperglycemia, it would be in a patients best interest to continue these medications in the perioperative setting